DRUGS · SERVICE DETAILS

Certification of drug labels

Check OTC Drug Facts or apply prescription drug labels, instructions and packaging information, together with product categories, listing basis, formulae and draft target labels, to form amendments and review agreed versions.

The label clearance is a data and compliance check service and does not represent the approval of the FDA label or the approval of the product for listing. Matters requiring a formal application or a change after approval shall be confirmed separately in accordance with the corresponding procedures.

SERVICE OVERVIEW

What does this service help with?

A clear application of the path and the examination of the material is followed by a cross-reference of label declarations, formulation strength, usage warnings, master information and product packaging data. Review lists, bases, recommendations for amendments and review records may be submitted to a problem location as agreed.

WHO MAY NEED IT

Who should consider this service?

Manufacturers, brand distributors and project information teams have or are preparing drug labels for people on the United States market. If the basis for listing or the key technical information is not clear, the gaps should be identified and road problems addressed.

SCOPE & APPROACH

What could be included in the drug label review?

The enterprises, products and existing records are checked before information responsibilities, delivery content and maintenance are defined.

01

Product path and validation baseline confirmation

Check the prescription or OTC identity, the basis for application or approval, the type and use of the agent, and identify the information to be reviewed and the prerequisites for which it cannot be judged.

02

OTC Drug Facts Content and Formatting

Check the content and layout of active ingredients, uses, warnings, usage, etc., in accordance with applicable rules and product requirements, and avoid direct translation or application of Chinese labels to the same product.

03

Consistency between prescription drug information and packaging

Check the consistency of instructions, containers and key markings in conjunction with the application of approved information and labelling requirements; Insufficient information is included in the list to be confirmed.

04

The composition, intensity and declaration.

Check label information against formulations, modes of delivery, target population and supporting information, indicating issues beyond the confirmed basis or need for additional evidence.

05

Main body, code and multipackaging check

Check the consistency of labeling enterprises, product packagings, NDCs, specifications and scripts to match the label text and images required for listing, and the actual listing is agreed separately.

06

List of issues and revised version of review

(b) The location of the delivery problem, the basis for the proposed changes and the review of the client’s revised text on an agreed basis, the retention of the version and pending matters; Printed layouts and formal supervision are submitted for confirmation.

GET READY

What to prepare for the assessment

A summary of the project and a catalogue of existing records may be provided first, and detailed documents may be transferred to confidentiality arrangements as authorized.

  • Product categories, listing paths or monograph assessments and information on associated approval labels
  • Complete formulation, composition intensity, formulation type, route of delivery and intended use
  • Descriptions, container labels, outer boxes and all designs for sale
  • Declares, uses warnings and supports technical information
  • Business label relationship, NDC and available listing information
  • Head of language review, revision, target time and information
HOW TO START

From initial review to engagement

STEP 01

Identification of products and clearance of boundaries

Identification of pathways, information base, tags to be reviewed and rounds of delivery and review.

STEP 02

Reconstructed on a case-by-case basis

Check the body, packaging and key data to distinguish between clear questions and information to be added.

STEP 03

Feedback issues and suggested changes

Delivery lists, corresponding locations and bases, communication of matters that require confirmation by the client or technical party.

STEP 04

Review of revised and handed over version

Reconciling agreed amendments, recording unresolved matters and subsequent submission or maintenance of interfaces.

The label clearance is a data and compliance check service and does not represent the approval of the FDA label or the approval of the product for listing. Matters requiring a formal application or a change after approval shall be confirmed separately in accordance with the corresponding procedures.

TIMING & FEES

Timing and fees

Information reviewed:Period of application of costs: reconciliation of official rules: 2026-11-06; The applicable user fees are applied separately from the current fiscal year according to the specific activity.

Timing and preparation

Document preparation

Delivery according to OTC or prescription drug information base, label language, layout specifications, declaration of complexity and review of rotational arrangements; (c) Completing the premises when there is a lack of basis for listing or technical information.

FDA processing

This item is a label information review and there is no uniform FDA review completion date. The procedure and timing of applications, supplementary applications or other formal regulatory changes are assessed separately.

Fee breakdown

FDA fees

There is no corresponding FDA application fee item for this consultancy; Official fees are charged separately if otherwise registered, applied or certified before listing.

Service fees

Review of round quotations by product, label and packaging version, depth of review, verification and revision; It is clear whether translations, rewriting, layouts and official submissions are included separately.

Other possible costs

Technical evidence, translation, design layout, testing and formal application support are listed on a practical basis; Label review delivery is not a substitute for the enterprise’s product safety and compliance responsibilities.

OFFICIAL SOURCES

Official basis of this service

Data check: 2026-11-06. Specific applicability and submission requirements should be identified in conjunction with real business.

START WITH YOUR PRODUCT

Starting with the product and the existing records.

Description of enterprise activities, products and available documentation, identification of information gaps, delivery, processing plans and quotations.